Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2016

01-04-2016

Variation in resources needed to implement psychosocial support interventions for rural breast cancer survivors

Authors: Maria Pisu, Karen Meneses, Andres Azuero, Rachel Benz, Xiaogang Su, Patrick McNees

Published in: Journal of Cancer Survivorship | Issue 2/2016

Login to get access

Abstract

Purpose

Understanding how resources are used provides guidance to disseminating effective interventions. Here, we report data on implementation resources needed for the Rural Breast Cancer Survivors (RBCS) study that tested a telephone-delivered psychoeducational education and support intervention to survivors in rural Florida. Intervention resources included interventionists’ time on one intake assessment (IA) call, three education calls (ED), one follow-up education call (FUE), six support (SUP) calls, and documentation time per survivor.

Methods

Interventionists logged start and end times of each type of call. Average interventionist time in minutes was calculated by call type. Associations between interventionists’ time and participants’ characteristics including age, race/ethnicity, time since treatment, cancer treatment, depressive symptoms, education, income, employment, and support, was assessed using linear mixed models with repeated measures.

Results

Among 328 survivors, IA calls lasted 66.9 min (SD 21.7); ED lasted 50.6 (SD 16.7), 48.1 (SD 15.9), and 39.6 (SD 14.8); FUE lasted 24.7 (SD 14.8); and SUP 42.8 (SD 29.6) min. Documentation time was 18.4 min for IA, 23–27 for ED, 12.3 for FUE, and 23.0 for SUP.

Conclusion

Interventionists spent significantly more time with participants with depressive symptoms, who already used other support, and who received SUP calls before the ED vs. after. There were no significant differences by time since or type of cancer treatment, or other personal characteristics.

Implications for Cancer Survivors

Resources vary by survivor characteristics. Careful consideration of mental health status or support available is warranted for planning implementation and dissemination of effective survivorship interventions on a broad scale.
Literature
1.
go back to reference Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102(7):1274–81.CrossRefPubMedPubMedCentral Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health. 2012;102(7):1274–81.CrossRefPubMedPubMedCentral
2.
go back to reference Mandelblatt JS, Cullen J, Lawrence WF, et al. Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008;26(10):1684–90.CrossRefPubMed Mandelblatt JS, Cullen J, Lawrence WF, et al. Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008;26(10):1684–90.CrossRefPubMed
3.
go back to reference Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005;23(25):6009–18.CrossRefPubMed Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005;23(25):6009–18.CrossRefPubMed
4.
go back to reference Neta G, Glasgow RE, Carpenter CR, et al. A framework for enhancing the value of research for dissemination and implementation. Am J Public Health. 2015;105(1):49–57.CrossRefPubMedPubMedCentral Neta G, Glasgow RE, Carpenter CR, et al. A framework for enhancing the value of research for dissemination and implementation. Am J Public Health. 2015;105(1):49–57.CrossRefPubMedPubMedCentral
5.
go back to reference Ribisl KM, Leeman J, Glasser AM. Pricing health behavior interventions to promote adoption: lessons from the marketing and business literature. Am J Prev Med. 2014;46(6):653–9.CrossRefPubMedPubMedCentral Ribisl KM, Leeman J, Glasser AM. Pricing health behavior interventions to promote adoption: lessons from the marketing and business literature. Am J Prev Med. 2014;46(6):653–9.CrossRefPubMedPubMedCentral
6.
go back to reference Meneses K, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA. Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum. 2007;34(5):1007–16.CrossRefPubMed Meneses K, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA. Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum. 2007;34(5):1007–16.CrossRefPubMed
7.
go back to reference Galway K, Black A, Cantwell M, Cardwell CR, Mills M, Donnelly M. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Datab of Syst Rev. 2012;11:CD007064. Galway K, Black A, Cantwell M, Cardwell CR, Mills M, Donnelly M. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Datab of Syst Rev. 2012;11:CD007064.
8.
go back to reference Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–7.CrossRefPubMedPubMedCentral Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–7.CrossRefPubMedPubMedCentral
9.
go back to reference Meneses K, McNees P, Azuero A, Loerzel VW, Su X, Hassey LA. Preliminary evaluation of psychoeducational support interventions on quality of life in rural breast cancer survivors after primary treatment. Cancer Nurs. 2009;32(5):385–97.CrossRefPubMedPubMedCentral Meneses K, McNees P, Azuero A, Loerzel VW, Su X, Hassey LA. Preliminary evaluation of psychoeducational support interventions on quality of life in rural breast cancer survivors after primary treatment. Cancer Nurs. 2009;32(5):385–97.CrossRefPubMedPubMedCentral
11.
go back to reference McNees P, Meneses K. Index of research access. Nurs Res Rev. 2012;3:5–7. McNees P, Meneses K. Index of research access. Nurs Res Rev. 2012;3:5–7.
12.
go back to reference Meneses K, Benz R, Hassey L, Yang Z, McNees P. Strategies to retain rural breast cancer survivors in longitudinal research. Appl Nurs Res. 2013;26(40):257–62.CrossRefPubMed Meneses K, Benz R, Hassey L, Yang Z, McNees P. Strategies to retain rural breast cancer survivors in longitudinal research. Appl Nurs Res. 2013;26(40):257–62.CrossRefPubMed
13.
go back to reference Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;1(3):385–401.CrossRef Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;1(3):385–401.CrossRef
14.
go back to reference Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124(3):437–43.CrossRefPubMedPubMedCentral Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124(3):437–43.CrossRefPubMedPubMedCentral
15.
go back to reference Pisu M, Azuero A, Meneses K, Burkhardt J, McNees P. Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Canc Res Tr. 2011;127(2):521–9.CrossRef Pisu M, Azuero A, Meneses K, Burkhardt J, McNees P. Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Canc Res Tr. 2011;127(2):521–9.CrossRef
16.
go back to reference Given BA, Given CW, Stommel M. Family and out-of-pocket costs for women with breast cancer. Cancer Pract. 1994;2(3):187–93.PubMed Given BA, Given CW, Stommel M. Family and out-of-pocket costs for women with breast cancer. Cancer Pract. 1994;2(3):187–93.PubMed
17.
18.
20.
go back to reference Stagl JM, Antoni MH, Lechner SC, et al. Randomized controlled trial of cognitive behavioral stress management in breast cancer: a brief report of effects on 5-Year depressive symptoms. Health Psychol. 2014;34(2):176–80.CrossRefPubMed Stagl JM, Antoni MH, Lechner SC, et al. Randomized controlled trial of cognitive behavioral stress management in breast cancer: a brief report of effects on 5-Year depressive symptoms. Health Psychol. 2014;34(2):176–80.CrossRefPubMed
21.
go back to reference Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010;304(2):163–71. doi:10.1001/jama.2010.944. Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010;304(2):163–71. doi:10.​1001/​jama.​2010.​944.
Metadata
Title
Variation in resources needed to implement psychosocial support interventions for rural breast cancer survivors
Authors
Maria Pisu
Karen Meneses
Andres Azuero
Rachel Benz
Xiaogang Su
Patrick McNees
Publication date
01-04-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0483-6

Other articles of this Issue 2/2016

Journal of Cancer Survivorship 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine